NSIX -- Neuromedical Systems, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NSIX -- Neuromedical Systems, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sigmund who wrote (20)	10/2/1997 10:35:00 PM
From: David and Elena Krikorian	of 137

Sigmund, Great post & I agree. The reason why the past CEO was pushed into another role with the co was that He was not doing a good enough marketing job with doctors, insurance co's, the public, etc. btw - I spoke w/investor relations group today and they have a short list of candidates. As I understand it, the test costs $40 (that's not very expensive) and is not an insurance covered cost. However, in one insurance network( I don't know the name - 18,000 doctors), a doctor must obtain written record from a women who is offered but refuses the PAPNET test. This is due to "it" being standard-of-care. Woman will pay for this test. It has to be marketed. Recent articles in the New York Post and a woman's mag are attempts to do this. A high profile CEO would do this. Goldman who owns 29% of the co would do this. Goldman cannot have anything to do with the company due to it's ownership role, however it's holding around 10,000,000 shares at a much higher cost (at least $15/share - $150 mil) and I don't think it want's to take that kind of a hit. Dave

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next